Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 160

1.

Prescription of antiviral drugs during the 2009 influenza pandemic: an observational study using electronic medical files of general practitioners in the Netherlands.

Hooiveld M, van de Groep T, Verheij TJ, van der Sande MA, Verheij RA, Tacken MA, van Essen GA.

BMC Pharmacol Toxicol. 2013 Oct 21;14:55. doi: 10.1186/2050-6511-14-55.

2.

Patterns in influenza antiviral medication use before and during the 2009 H1N1 pandemic, Vaccine Safety Datalink Project, 2000-2010.

Greene SK, Shay DK, Yin R, McCarthy NL, Baxter R, Jackson ML, Jacobsen SJ, Nordin JD, Irving SA, Naleway AL, Glanz JM, Lieu TA.

Influenza Other Respir Viruses. 2012 Nov;6(6):e143-51. doi: 10.1111/j.1750-2659.2012.00390.x. Epub 2012 Jun 11.

3.

Oseltamivir use and outcomes during the 2009 influenza A H1N1 pandemic in Taiwan.

Liu CH, Wang JL, Su CP, Chuang JH, Chang CH, Lai MS.

BMC Public Health. 2013 Jul 12;13:646. doi: 10.1186/1471-2458-13-646.

4.

U.S. utilization patterns of influenza antiviral medications during the 2009 H1N1 influenza pandemic.

Borders-Hemphill V, Mosholder A.

Influenza Other Respir Viruses. 2012 Nov;6(6):e129-33. doi: 10.1111/j.1750-2659.2012.00384.x. Epub 2012 Jun 9.

5.

[New influenza A (H1N1): advised indication and prescription of antiviral drugs].

van den Wijngaard CC, van Steenbergen JE, van der Sande MA, Koopmans MP.

Ned Tijdschr Geneeskd. 2009;153:A1053. Dutch.

PMID:
19857317
6.

Rapid influenza diagnostic test use and antiviral prescriptions in outpatient settings pre- and post-2009 H1N1 pandemic.

Williams LO, Kupka NJ, Schmaltz SP, Barrett S, Uyeki TM, Jernigan DB.

J Clin Virol. 2014 May;60(1):27-33. doi: 10.1016/j.jcv.2014.01.016. Epub 2014 Feb 12.

PMID:
24630481
7.

Evaluation of diagnostic and therapeutic approaches for suspected influenza A(H1N1)pdm09 infection, 2009-2010.

Vijayan V, Jing J, Zangwill KM.

Emerg Infect Dis. 2012 Sep;18(9):1414-21. doi: 10.3201/eid1809.111564.

8.

Epidemiological characteristics of novel influenza A (H1N1) in antiviral drug users in Korea.

Choi K, Cho SI, Hashizume M, Kim H.

PLoS One. 2012;7(10):e47634. doi: 10.1371/journal.pone.0047634. Epub 2012 Oct 17.

9.

Oseltamivir and the risk of influenza-related complications and hospitalizations in patients with diabetes.

Orzeck EA, Shi N, Blumentals WA.

Clin Ther. 2007 Oct;29(10):2246-55.

PMID:
18042482
10.

Reducing occurrence and severity of pneumonia due to pandemic H1N1 2009 by early oseltamivir administration: a retrospective study in Mexico.

Higuera Iglesias AL, Kudo K, Manabe T, Corcho Berdugo AE, Corrales Baeza A, Alfaro Ramos L, Guevara Gutiérrez R, Manjarrez Zavala ME, Takasaki J, Izumi S, Bautista E, Perez Padilla JR.

PLoS One. 2011;6(7):e21838. doi: 10.1371/journal.pone.0021838. Epub 2011 Jul 8.

11.

Antiviral drugs in influenza: an adjunct to vaccination in some situations.

[No authors listed]

Prescrire Int. 2006 Feb;15(81):21-30.

PMID:
16548114
12.

Oseltamivir-resistant pandemic A(H1N1) 2009 influenza viruses detected through enhanced surveillance in the Netherlands, 2009-2010.

Meijer A, Jonges M, Abbink F, Ang W, van Beek J, Beersma M, Bloembergen P, Boucher C, Claas E, Donker G, van Gageldonk-Lafeber R, Isken L, de Jong A, Kroes A, Leenders S, van der Lubben M, Mascini E, Niesters B, Oosterheert JJ, Osterhaus A, Riesmeijer R, Riezebos-Brilman A, Schutten M, Sebens F, Stelma F, Swaan C, Timen A, van 't Veen A, van der Vries E, te Wierik M, Koopmans M.

Antiviral Res. 2011 Oct;92(1):81-9. doi: 10.1016/j.antiviral.2011.07.004. Epub 2011 Jul 13.

PMID:
21767571
13.

Safety profile of oseltamivir during the 2009 influenza pandemic.

Donner B, Bader-Weder S, Schwarz R, Peng MM, Smith JR, Niranjan V.

Pharmacoepidemiol Drug Saf. 2011 May;20(5):532-43. doi: 10.1002/pds.2136.

PMID:
21448900
14.

Treatment with oseltamivir in children hospitalized with community-acquired, laboratory-confirmed influenza: review of five seasons and evaluation of an electronic reminder.

Wilkes JJ, Zaoutis TE, Keren R, Desai B, Leckerman KH, Hodinka RL, Metjian TA, Coffin SE.

J Hosp Med. 2009 Mar;4(3):171-8. doi: 10.1002/jhm.431.

PMID:
19301375
15.

Estimating effect of antiviral drug use during pandemic (H1N1) 2009 outbreak, United States.

Atkins CY, Patel A, Taylor TH Jr, Biggerstaff M, Merlin TL, Dulin SM, Erickson BA, Borse RH, Hunkler R, Meltzer MI.

Emerg Infect Dis. 2011 Sep;17(9):1591-8. doi: 10.3201/eid1709.110295.

16.

Clinical aspects of 2009 pandemic influenza A (H1N1) virus infection in Austria.

Poeppl W, Hell M, Herkner H, Stoiser B, Fritsche G, Schurz-Bamieh N, Poeppl G, Gattringer R, Jones N, Maass M, Egle A, Burgmann H.

Infection. 2011 Aug;39(4):341-52. doi: 10.1007/s15010-011-0121-9. Epub 2011 May 5.

PMID:
21544585
17.

Description of antiviral treatment among adults hospitalized with influenza before and during the 2009 pandemic: United States, 2005-2009.

Doshi S, Kamimoto L, Finelli L, Perez A, Reingold A, Gershman K, Yousey-Hindes K, Arnold K, Ryan P, Lynfield R, Morin C, Baumbach J, Hancock EB, Bennett NM, Zansky S, Thomas A, Schaffner W, Fry AM.

J Infect Dis. 2011 Dec 15;204(12):1848-56. doi: 10.1093/infdis/jir648. Epub 2011 Oct 19.

PMID:
22013219
18.

Degree of adherence to recommended antiviral treatment during the pandemic and post-pandemic periods of influenza A(H1N1)pdm09 in 148 intensive care units in Spain.

Canadell L, Martín-Loeches I, Díaz E, Trefler S, Grau S, Yebenes JC, Almirall J, Olona M, Sureda F, Blanquer J, Rodriguez A; GETGAG..

Med Intensiva. 2015 May;39(4):222-33. doi: 10.1016/j.medin.2014.06.001. Epub 2014 Aug 5. English, Spanish.

19.

Clinical and epidemiological characteristics of patients with influenza A (H1N1) 2009 attended to at the emergency room of a children's hospital.

Lera E, Wörner NT, Sancosmed M, Fàbregas A, Casquero A, Melendo S, Miserachs M, Tórtola T, Borrego A, Campins M, Moraga F, Figueras C, Cebrián R.

Eur J Pediatr. 2011 Mar;170(3):371-8. doi: 10.1007/s00431-011-1399-4. Epub 2011 Jan 28.

PMID:
21274563
20.

Triple-combination antiviral drug for pandemic H1N1 influenza virus infection in critically ill patients on mechanical ventilation.

Kim WY, Young Suh G, Huh JW, Kim SH, Kim MJ, Kim YS, Kim HR, Ryu YJ, Han MS, Ko YG, Chon GR, Lee KH, Choi SH, Hong SB; Korean Society of Critical Care Medicine H1N1 Collaborative..

Antimicrob Agents Chemother. 2011 Dec;55(12):5703-9. doi: 10.1128/AAC.05529-11. Epub 2011 Oct 3.

Supplemental Content

Support Center